X4 Pharmaceuticals (XFOR) Interest Coverage Ratio (QoQ) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | X4 Pharmaceuticals | 182.28 Mn | 182.28 Mn | 2.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.05% |
| Sep 30, 2025 | -3.71% |
| Jun 30, 2025 | -173.93% |
| Mar 31, 2025 | 72.32% |
| Dec 31, 2024 | -8.46% |
| Sep 30, 2024 | -143.74% |
| Jun 30, 2024 | 264.22% |
| Mar 31, 2024 | -48.93% |
| Dec 31, 2023 | 19.78% |
| Sep 30, 2023 | 25.91% |
| Jun 30, 2023 | 14.93% |
| Mar 31, 2023 | -18.19% |
| Dec 31, 2022 | -12.93% |
| Sep 30, 2022 | 11.65% |
| Jun 30, 2022 | 3.81% |
| Mar 31, 2022 | 25.84% |
| Dec 31, 2021 | -51.15% |
| Sep 30, 2021 | 1.00% |
| Jun 30, 2021 | -4.28% |
| Mar 31, 2021 | 17.91% |
| Dec 31, 2020 | -0.65% |
| Sep 30, 2020 | -14.18% |
| Jun 30, 2020 | -17.76% |
| Mar 31, 2020 | 8.70% |
| Dec 31, 2019 | 19.57% |
| Sep 30, 2019 | 5.82% |
| Jun 30, 2019 | -0.15% |
| Mar 31, 2019 | 23.34% |
| Dec 31, 2018 | 40.89% |
| Sep 30, 2018 | -51.22% |
| Jun 30, 2018 | -5.60% |
| Mar 31, 2018 | -1,986.77% |
| Dec 31, 2017 | 95.45% |
| Sep 30, 2017 | -199.44% |
| Jun 30, 2017 | -122.30% |